Transient splenium lesions in presurgical epilepsy patients: incidence and pathogenesis
暂无分享,去创建一个
H. Urbach | M. Kurthen | C. Bien | M. Nelles | H. Urbach | M. Kurthen | M. von Falkenhausen | M. Nelles | C. G. Bien | M. Falkenhausen
[1] T. Shimono,et al. Transient splenial lesion of the corpus callosum associated with antiepileptic drugs: evaluation by diffusion-weighted MR imaging , 2003, European Radiology.
[2] J. Shiota,et al. Marchiafava‐bignami disease: Computed tomographic scan and magnetic resonance imaging , 1985, Annals of neurology.
[3] M. Han,et al. Marchiafava-Bignami disease: serial changes in corpus callosum on MRI , 2004, Neuroradiology.
[4] K. Kieburtz,et al. Magnetic resonance imaging findings in HIV cognitive impairment. , 1990, Archives of neurology.
[5] A. Ebner,et al. Transient lesion in the splenium of the corpus callosum: three further cases in epileptic patients and a pathophysiological hypothesis , 2001, Journal of neurology, neurosurgery, and psychiatry.
[6] T. Taoka,et al. Clinically mild encephalitis/encephalopathy with a reversible splenial lesion , 2004, Neurology.
[7] Donald H. Lee,et al. Transient lesion in the splenium of the corpus callosum in an epileptic patient , 2003, Neurology.
[8] N. Kondo,et al. Transient Lesion in the Splenium of the Corpus Callosum in Acute Cerebellitis , 2003, Journal of child neurology.
[9] H. Levin,et al. Corpus callosum lesions after closed head injury in children: MRI, clinical features and outcome , 2004, Neuroradiology.
[10] N. Watson,et al. Clinical implications of splenium magnetic resonance imaging signal changes. , 2005, Archives of neurology.
[11] M. Han,et al. Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? , 1999, AJNR. American journal of neuroradiology.
[12] J. Villanúa,et al. Marchiafava-Bignami disease with widespread extracallosal lesions and favourable course , 1999, Neuroradiology.
[13] H. Tsukahara,et al. Reversible Diffusion-Weighted MR Findings of Salmonella enteritidis-Associated Encephalopathy , 2003, European Neurology.
[14] B. Buchbinder,et al. Pregabalin‐withdrawal encephalopathy and splenial edema: A link to high‐altitude illness? , 2005, Annals of neurology.
[15] E. Caumes,et al. MR of cerebral malaria. , 1998, AJNR. American journal of neuroradiology.
[16] F. Cotton,et al. Diffusion-weighted magnetic resonance imaging in Marchiafava–Bignami disease: follow-up studies , 2005, Neuroradiology.
[17] H. Petit,et al. Marchiafava-Bignami disease: use of contrast media in CT and MRI , 1994, Neuroradiology.
[18] Morihiro Sugishita,et al. Diffusion-weighted imaging demonstrates transient cytotoxic edema involving the corpus callosum in a patient with diffuse brain injury , 2000, Clinical Neurology and Neurosurgery.
[19] A. Jenkins,et al. Postmortem tissue distribution of olanzapine and citalopram in a drug intoxication. , 2005, Journal of forensic sciences.
[20] P. Hackett,et al. High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. , 1998, JAMA.
[21] K. Voigt,et al. Classification of acquired lesions of the corpus callosum with MRI , 2000, Neuroradiology.
[22] A. Barkovich,et al. Influenza-associated encephalitis/encephalopathy with a reversible lesion in the splenium of the corpus callosum: a case report and literature review. , 2004, AJNR. American journal of neuroradiology.
[23] T. Shimazu,et al. Reversible MR findings of hemolytic uremic syndrome with mild encephalopathy. , 1998, AJNR. American journal of neuroradiology.
[24] M. Oka,et al. Diffusion‐weighted magnetic resonance imaging in early stage of 5‐fluorouracil‐induced leukoencephalopathy , 2002, Acta neurologica Scandinavica.
[25] D. Birchall,et al. Reversible abnormalities of DWI in high-altitude cerebral edema , 2004, Neurology.
[26] C. Jack,et al. Transient postictal magnetic resonance imaging abnormality of the corpus callosum in a patient with epilepsy. Case report and review of the literature. , 2002, Journal of neurosurgery.
[27] A. Falini,et al. Marchiafava-Bignami disease: longitudinal MR imaging and MR spectroscopy study. , 2003, AJNR. American journal of neuroradiology.
[28] A. Gass,et al. Marchiafava-Bignami disease: reversibility of neuroimaging abnormality. , 1998, Journal of computer assisted tomography.
[29] K. Ashkar,et al. Neuroleptic malignant syndrome with olanzapine associated with severe hypernatremia , 2001, Human psychopharmacology.
[30] B. Silver,et al. Hyponatremia Associated with Repeated Use of Levetiracetam , 2005, Epilepsia.
[31] Mirela V. Simon,et al. Diffusion‐weighted Imaging Abnormalities in the Splenium after Seizures , 2003, Epilepsia.
[32] Martin Kurthen,et al. MR imaging in the presurgical workup of patients with drug-resistant epilepsy. , 2004, AJNR. American journal of neuroradiology.
[33] A. Edefonti,et al. Central nervous system involvement in a child with hemolytic uremic syndrome , 2000, Pediatric Nephrology.
[34] H. Tsukahara,et al. Transient MR signal changes in the splenium of the corpus callosum in rotavirus encephalopathy: value of diffusion-weighted imaging. , 2002, Journal of computer assisted tomography.